Skip to content

Contact +44 (0) 20 7060 7474 email us

Search Results


The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Quetiapine: Pipeline™ Selector'

Title Publication Date Price Relevance
Quetiapine
Pipeline Developer
Ongoing £2925 100 %
Quetiapine: Core Country Coverage
Pipeline Selector
Ongoing £260 96 %
Quetiapine: Extended Country Coverage
Pipeline Selector
Ongoing £610 96 %
Pipeline Insight: Bipolar Disorder
New treatments for bipolar depression set to drive near-term growth
September 2006 £6495 50 %
Schizophrenia in Focus
August 2006 £29.95 35 %
Commercial Insight: Depression
Atypical lifecycle management strategy rejuvenates depression market
June 2007 £7600 34.5 %
CNS Market Trends, 2007 to 2010
Key Market Forecasts and Growth Opportunities
June 2007 £995 33.25 %
Astellas
Pipeline Products Performance Potential
June 2008 £595 24.5 %
Pipeline Insight: Anxiety Disorders
A decade of declining revenues
March 2006 £6495 20.3 %
Pipeline Insight: Depression
Novel drugs to grow third-line market
March 2007 £6000 19.6 %
Teva Generics Company Intelligence Report
Company Intelligence Report
March 2009 £195 18.9 %
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
October 2008 £8000 17.5 %
Pipeline Insight: Schizophrenia
July 2006 £6330 14.7 %
Teva Pharmaceutical Industries Generics Company Intelligence Report
June 2008 £195 13.3 %
Pipeline and Commercial Insight: Anxiety Disorders Viable indication for antipsychotics companies
November 2008 £8000 12.25 %
Stakeholder Opinions: Parkinson's Disease
Review of Key Commercial Opportunities in the Symptomatic Treatment Market
July 2006 £2230 8.75 %
Generic Competition, 2007–11
The impact of patent expiries on sales of major drugs
February 2007 £1375 8.4 %
CNS Generic Drugs: Prospects and Opportunities to 2012
April 2008 £995 5.95 %
Handbook of Pharmaceutical Manufacturing Formulations - Vol 1 of 6
Compressed Solid Products
April 2007 £195 5.6 %
World Generic Market Report 2009
January 2009 £595 3.15 %